← Alle mensen

PC

Paul Cislo

3 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

First-line talazoparib plus enzalutamide versus placebo plus enzalutamide for metastatic castration-resistant prostat...

The Lancet. Oncology · 2025-04

First-line talazoparib plus enzalutamide versus placebo plus enzalutamide in men with metastatic castration-resistant...

The Lancet. Oncology · 2025-04

Effect van radium-223 op ziekenhuisopname: analyse uit de ALSYMPCA fase III-studie

European journal of cancer (Oxford, England : 1990) · 2017-01